Maria Giovanna Marrosu
Maria Giovanna Marrosu
Professor of Neurology, University of Cagliari
Verifierad e-postadress på unica.it
Titel
Citeras av
Citeras av
År
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
8212005
Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy
F Muntoni, M Cau, A Ganau, R Congiu, G Arvedi, A Mateddu, MG Marrosu, ...
New England Journal of Medicine 329 (13), 921-925, 1993
5161993
Selective expression of adhesion molecules on human brain microvascular endothelial cells
MF Stins, F Gilles, KS Kim
Journal of neuroimmunology 76 (1-2), 81-90, 1997
4031997
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1268-1283. e6, 2018
2162018
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
GL Mancardi, R Saccardi, M Filippi, F Gualandi, A Murialdo, M Inglese, ...
Neurology 57 (1), 62-68, 2001
1972001
Overexpression of the cytokine BAFF and autoimmunity risk
M Steri, V Orrù, ML Idda, M Pitzalis, M Pala, I Zara, C Sidore, V Faà, ...
New England Journal of Medicine 376 (17), 1615-1626, 2017
1922017
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72
A Chiò, G Borghero, G Restagno, G Mora, C Drepper, BJ Traynor, ...
Brain 135 (3), 784-793, 2012
1902012
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis
S Sanna, M Pitzalis, M Zoledziewska, I Zara, C Sidore, R Murru, ...
Nature genetics 42 (6), 495-497, 2010
1902010
Prospective study of multiple sclerosis with early onset
A Ghezzi, C Pozzilli, M Liguori, MG Marrosu, N Milani, C Milanese, ...
Multiple Sclerosis Journal 8 (2), 115-118, 2002
1902002
Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene
MG Marrosu, S Vaccargiu, G Marrosu, A Vannelli, C Cianchetti, F Muntoni
Neurology 50 (5), 1397-1401, 1998
1871998
Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia
MG Marrosu, R Murru, MR Murru, G Costa, P Zavattari, M Whalen, ...
Human molecular genetics 10 (25), 2907-2916, 2001
1822001
Age‐related disability in multiple sclerosis
M Trojano, M Liguori, G Bosco Zimatore, R Bugarini, C Avolio, D Paolicelli, ...
Annals of Neurology: Official Journal of the American Neurological …, 2002
1712002
DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population
MG Marrosu, MR Murru, G Costa, R Murru, F Muntoni, F Cucca
Human molecular genetics 7 (8), 1235-1237, 1998
1601998
Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings
AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ...
Neurology 89 (11), 1117-1126, 2017
1582017
Sardinian multiple sclerosis is associated with HLA‐DR4: A serologic and molecular analysis
MG Marrosu, F Muntoni, MR Murru, G Spinicci, MP Pischedda, F Goddi, ...
Neurology 38 (11), 1749-1749, 1988
1581988
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis
MP Amato, E Portaccio, A Ghezzi, B Hakiki, V Zipoli, V Martinelli, L Moiola, ...
Neurology 75 (20), 1794-1802, 2010
1552010
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity
C Sardu, E Cocco, A Mereu, R Massa, A Cuccu, MG Marrosu, P Contu
PloS one 7 (3), e32487, 2012
1462012
Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and-DR4 alleles.
MG Marrosu, MR Murru, G Costa, F Cucca, S Sotgiu, G Rosati, F Muntoni
American journal of human genetics 61 (2), 454, 1997
1411997
A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.
F Muntoni, L Wilson, G Marrosu, MG Marrosu, C Cianchetti, L Mestroni, ...
The Journal of clinical investigation 96 (2), 693-699, 1995
1341995
Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy
E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ...
Neurology 89 (11), 1107-1116, 2017
1282017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20